- Argirion, Ilona;
- Mahale, Parag;
- Pfeiffer, Ruth M;
- Liu, Ping;
- Adimora, Adaora A;
- Akiyama, Matthew J;
- Bolivar, Hector H;
- French, Audrey;
- Plankey, Michael;
- Price, Jennifer C;
- Rana, Aadia;
- Sheth, Anandi;
- Koshiol, Jill;
- Seaberg, Eric C;
- Kuniholm, Mark H;
- Glenn, Jeffrey;
- O’Brien, Thomas R
Hepatitis D virus (HDV) requires co-infection with hepatitis B virus (HBV). Human immunodeficiency virus (HIV) shares transmission routes with these viruses. Among 4,932 US women infected with or at-risk for HIV during 1994-2015, HBV surface antigen (HBsAg) positivity was more common in women with HIV (2.8% vs. 1.2%; p = 0.001); HDV was more common among participants enrolled during 2013-2015 (p = 0.0004) and those with resolved rather than active hepatitis C (1.9% vs. 0.5%; p = 0.02). Among HBsAg-positive women (n = 117), HDV antibody prevalence was 22% and did not vary by HIV status; HDV infection was associated with the presence of advanced fibrosis/cirrhosis at enrollment (adjusted odds ratio, 5.70; 95% confidence interval, 1.46-22.29). Our results demonstrate the importance of HDV testing in HBV-infected US women.